澳大利亚和新西兰Fontan注册研究:圆锥动脉干异常患者Fontan手术结局分析(1835例)
该研究基于澳大利亚和新西兰Fontan注册数据,回顾1975至2023年1835例Fontan手术患者,其中895例(49%)合并圆锥动脉干异常。中位随访11.7年,合并与不合并圆锥动脉干异常的患者在20年无移植生存率和无Fontan失败率上无显著差异,但圆锥动脉干异常患者起搏器植入和流出道再干预更常见。
要点
- 圆锥动脉干异常患者与无此异常者20年无移植生存率和无Fontan失败率无显著差异。
- 圆锥动脉干异常患者起搏器植入率更高(11.2% vs 8.3%,P=0.038)。
- 圆锥动脉干异常患者流出道再干预(含半月瓣)发生率更高(P<0.001)。
核心结论
- 合并圆锥动脉干异常的患者与不合并者在Fontan术后长期生存和无Fontan失败率上无显著差异。
- 合并圆锥动脉干异常的患者流出道再干预(包括半月瓣)和起搏器植入发生率更高。
研究设计与样本
- 回顾性队列研究,基于澳大利亚和新西兰Fontan注册数据,纳入1975至2023年1835例Fontan手术患者。
主要发现
- 圆锥动脉干异常见于895例(49%),包括D-TGA(n=476)、右室双出口(n=360)和L-TGA(n=170)。
- 中位随访11.7年(IQR 5.3-20.3年),20年无移植生存率84%(95%CI 81-87%),无Fontan失败率72%(95%CI 68-75%)。
- 合并与不合并圆锥动脉干异常的患者在生存(P=0.50)和无Fontan失败(P=0.83)上无差异。
- 起搏器植入在圆锥动脉干异常患者中更常见(11.2% vs 8.3%,P=0.038)。
- 45例患者接受流出道再干预(包括半月瓣),30年无再干预率95%(95%CI 93-96%),圆锥动脉干异常患者更高(P<0.001)。
临床怎么用
- 对合并圆锥动脉干异常的Fontan患者,应关注流出道再干预和起搏器植入风险,长期随访中加强监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The impact of conotruncal anomalies (CTAs), including tetralogy of Fallot, truncus arteriosus, ventriculo-arterial discordance, double-outlet right ventricle and interrupted aortic arch type B, on long-term outcomes remains poorly described in the Fontan cohort. We sought to review the outcomes of Fontan patients with CTAs in Australia and New Zealand. METHODS: We reviewed the data from 1835 patients who underwent a Fontan operation between 1975 and 2023 from the Australia and New Zealand Fontan Registry. RESULTS: CTAs occurred in 895 patients (49%), including D-TGA (Transposition of Great Arteries) (n = 476), double-outlet right ventricle (n = 360) and L-TGA (n = 170). Patients with CTAs had more heterotaxy syndrome (11.3% vs 6.8%, P < 0.001) and less left-ventricular dominance (53% vs 60%, P = 0.011). Median follow-up was 11.7 years (IQR: 5.3-20.3 years). Overall transplant-free survival and freedom from Fontan failure was 84% (95% confidence interval: 81-87%) and 72% (95% confidence interval: 68-75%) at 20 years, respectively. No difference was demonstrated in survival or freedom from Fontan failure between patients with or without CTAs (P = 0.50 and P = 0.83). Pacemaker implantation was more common in patients with CTAs (11.2% vs 8.3%, P = 0.038). Overall, 45 patients underwent outflow tract reinterventions, including semilunar valves, 'after' Fontan operation. Freedom from these reinterventions was 95% (95% confidence interval: 93-96%) at 30 years and was higher in patients with CTAs (P < 0.001). CONCLUSIONS: Patients with CTAs did not have a demonstrable difference in long-term survival and freedom from Fontan failure to other patients undergoing Fontan operation. Patients with CTAs have higher incidence of outflow tract reinterventions, including semilunar valves, and higher rate of pacemaker implantation.
引用
- Daley M, Cordina R, Alphonso N, et al. Outcomes of Fontan operation in patients with conotruncal anomalies from Australia and New Zealand Fontan Registry: a review of 1835 patients†. Eur J Cardiothorac Surg. 2025. PMID: 40065689. doi:10.1093/ejcts/ezaf070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。